Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BFLY Butterfly Network	$1.64 +4.1%	$1.73	$1.00 ▼ $4.98	$395.23M	2.45	4.07 million shs	3.12 million shs
ESTA Establishment Labs	$41.00 -3.4%	$41.22	$26.56 ▼ $50.85	$1.23B	0.83	493,272 shs	295,309 shs
NVCR NovoCure	$12.02 +0.9%	$14.32	$10.87 ▼ $34.13	$1.33B	0.61	1.74 million shs	1.35 million shs
SSII SS Innovations International	$7.00 -3.0%	$6.46	$0.32 ▼ $22.42	$1.40B	N/A	48,243 shs	34,672 shs

These 7 Stocks Will Be Magnificent in 2025

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BFLY Butterfly Network	-0.63%	+11.31%	-18.39%	-35.77%	+59.82%
ESTA Establishment Labs	+1.63%	+8.57%	-0.09%	+22.38%	-8.28%
NVCR NovoCure	+0.68%	+1.10%	+2.32%	-38.61%	-33.83%
SSII SS Innovations International	+2.12%	+12.11%	+0.28%	+19.73%	+721,999,900.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BFLY Butterfly Network	3.066 of 5 stars	3.4	3.0	0.0	0.0	2.4	3.3	0.6
ESTA Establishment Labs	1.8682 of 5 stars	3.4	0.0	0.0	0.0	2.0	2.5	0.6
NVCR NovoCure	4.1505 of 5 stars	3.3	2.0	0.0	4.5	3.1	3.3	0.0
SSII SS Innovations International	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BFLY Butterfly Network	2.75	Moderate Buy	$3.00	83.49% Upside
ESTA Establishment Labs	2.83	Moderate Buy	$56.50	37.80% Upside
NVCR NovoCure	2.57	Moderate Buy	$28.79	139.48% Upside
SSII SS Innovations International	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest BFLY, NVCR, SSII, and ESTA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/20/2025	ESTA Establishment Labs	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$60.00
8/4/2025	BFLY Butterfly Network	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Positive ➝ Positive	$2.00
8/1/2025	BFLY Butterfly Network	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Market Perform
7/25/2025	NVCR NovoCure	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Equal Weight	$40.00 ➝ $14.50
7/16/2025	ESTA Establishment Labs	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$58.00 ➝ $70.00
7/9/2025	ESTA Establishment Labs	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$38.00 ➝ $47.00
7/8/2025	NVCR NovoCure	LADENBURG THALM/SH SH Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$30.00
7/1/2025	BFLY Butterfly Network	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$3.00
6/27/2025	NVCR NovoCure	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$34.00
6/13/2025	ESTA Establishment Labs	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$48.00

(Data available from 8/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BFLY Butterfly Network	$82.06M	5.02	N/A	N/A	$0.92 per share	1.78
ESTA Establishment Labs	$166.02M	7.15	N/A	N/A	$0.79 per share	51.90
NVCR NovoCure	$630.16M	2.13	N/A	N/A	$3.13 per share	3.84
SSII SS Innovations International	$20.65M	65.62	N/A	N/A	$0.22 per share	31.82

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BFLY Butterfly Network	-$72.49M	-$0.28	N/A	N/A	N/A	-71.79%	-30.53%	-21.80%	11/7/2025 (Estimated)
ESTA Establishment Labs	-$84.60M	-$3.05	0.00	N/A	N/A	-49.89%	-224.34%	-25.53%	11/6/2025 (Estimated)
NVCR NovoCure	-$168.63M	-$1.56	N/A	N/A	N/A	-27.13%	-47.74%	-13.79%	10/29/2025 (Estimated)
SSII SS Innovations International	-$19.15M	N/A	0.00	∞	N/A	-40.20%	-40.41%	-20.80%	N/A

Latest BFLY, NVCR, SSII, and ESTA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2025	Q2 2025	ESTA Establishment Labs	-$0.54	-$0.57	-$0.03	-$0.57	$50.80 million	$51.30 million
8/1/2025	Q2 2025	BFLY Butterfly Network	-$0.07	-$0.06	+$0.01	-$0.06	$23.91 million	$23.38 million
7/24/2025	Q2 2025	NVCR NovoCure	-$0.39	-$0.36	+$0.03	-$0.36	$153.87 million	$158.80 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BFLY Butterfly Network	N/A	N/A	N/A	N/A	N/A
ESTA Establishment Labs	N/A	N/A	N/A	N/A	N/A
NVCR NovoCure	N/A	N/A	N/A	N/A	N/A
SSII SS Innovations International	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BFLY Butterfly Network	N/A	5.68	4.14
ESTA Establishment Labs	9.71	2.84	1.67
NVCR NovoCure	0.28	1.45	1.39
SSII SS Innovations International	N/A	2.59	1.66

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BFLY Butterfly Network	37.85%
ESTA Establishment Labs	72.91%
NVCR NovoCure	84.61%
SSII SS Innovations International	N/A

Insider Ownership

Company	Insider Ownership
BFLY Butterfly Network	25.18%
ESTA Establishment Labs	11.09%
NVCR NovoCure	5.52%
SSII SS Innovations International	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BFLY Butterfly Network	460	251.74 million	188.35 million	Optionable
ESTA Establishment Labs	1,018	28.97 million	25.76 million	Optionable
NVCR NovoCure	1,488	111.80 million	105.63 million	Optionable
SSII SS Innovations International	4	193.59 million	N/A	N/A

BFLY, NVCR, SSII, and ESTA Headlines

Recent News About These Companies

SS Innovations International (NASDAQ:SSII) Stock Price Up 17.1% - Still a Buy?

August 24, 2025 | marketbeat.com

SS Innovations International (NASDAQ:SSII) Shares Gap Down - Time to Sell?

August 20, 2025 | marketbeat.com

SS Innovations International (NASDAQ:SSII) Shares Gap Up - Should You Buy?

August 16, 2025 | marketbeat.com

SS Innovations International Inc. Stock Grades | SSII | Barron's

August 15, 2025 | barrons.com

SS Innovations International (NASDAQ:SSII) Stock Price Down 8% - What's Next?

August 12, 2025 | marketbeat.com

Ss Innovations (SSII) Q2 Revenue Up 122%

August 8, 2025 | aol.comA

SS Innovations Reports Second Quarter 2025 Financial Results

August 7, 2025 | prismmediawire.comP

SS Innovations Reports Second Quarter 2025 Financial Results

August 7, 2025 | globenewswire.com

SS Innovations Announces Completion of World’s First Intercontinental Robotic Cardiac Telesurgery

July 23, 2025 | finance.yahoo.com

SS Innovations Announces Completion of World's First Intercontinental Robotic Cardiac Telesurgery

July 22, 2025 | prismmediawire.comP

SS Innovations Announces Completion of World's First Intercontinental Robotic Cardiac Telesurgery

July 22, 2025 | globenewswire.com

SSII - SS Innovations International Inc Ownership | Morningstar

July 17, 2025 | morningstar.comM

SS Innovations Surpasses Milestone of 100 Installations of the SSi Mantra Surgical Robotic System

July 15, 2025 | prismmediawire.comP

SS Innovations Announces Completion of World's First Robotic Telesurgery for Weight Loss with the Company's SSi Mantra 3 Surgical Robotic System

July 10, 2025 | prismmediawire.comP

SS Innovations Announces Completion of World's First Robotic Telesurgery for Weight Loss with the Company's SSi Mantra 3 Surgical Robotic System

July 10, 2025 | globenewswire.com

SS Innovations: A Speculative Bet On Robotic Surgeries

June 19, 2025 | seekingalpha.com

SS Innovations Announces Successful Completion of First Robotic Cardiac Surgery in the Western Hemisphere Utilizing the Company's SSi Mantra 3 Surgical Robotic System

June 16, 2025 | prismmediawire.comP

SS Innovations Announces Successful Completion of First Robotic Cardiac Surgery in the Western Hemisphere Utilizing the Company's SSi Mantra 3 Surgical Robotic System

June 16, 2025 | globenewswire.com

SS Innovations Surpasses Milestone of 4,000 Robotic Surgeries Successfully Performed with the SSi Mantra Surgical Robotic System

May 27, 2025 | prismmediawire.comP

SS Innovations Surpasses Milestone of 4,000 Robotic Surgeries Successfully Performed with the SSi Mantra Surgical Robotic System

May 27, 2025 | globenewswire.com

SS Innovations Reports First Quarter 2025 Financial Results

May 14, 2025 | prismmediawire.comP

New MarketBeat Followers Over Time

Media Sentiment Over Time

BFLY, NVCR, SSII, and ESTA Company Descriptions

Butterfly Network NYSE:BFLY

$1.64 +0.07 (+4.14%)

Closing price 03:59 PM Eastern

Extended Trading

$1.64 +0.00 (+0.31%)

As of 07:59 PM Eastern

Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as professional services for large scale deployments; and ScanLab, an education-only app provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.

Establishment Labs NASDAQ:ESTA

$41.00 -1.44 (-3.39%)

Closing price 04:00 PM Eastern

Extended Trading

$41.00 +0.00 (+0.00%)

As of 06:06 PM Eastern

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

NovoCure NASDAQ:NVCR

$12.02 +0.11 (+0.92%)

Closing price 04:00 PM Eastern

Extended Trading

$12.04 +0.02 (+0.12%)

As of 07:33 PM Eastern

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.

SS Innovations International NASDAQ:SSII

$7.00 -0.22 (-3.05%)

As of 04:00 PM Eastern

AVRA Medical Robotics, Inc. develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc. and changed its name to AVRA Medical Robotics, Inc. in November 2015. AVRA Medical Robotics, Inc. was founded in 2015 and is based in Orlando, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time